Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Latanoprost can effectively treat eyelash hair loss, with 45% of patients showing hair regrowth and no reported side effects.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Some babies are born with alopecia areata, and a treatment with clobetasol propionate can regrow hair in half of the cases.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Alopecia areata involves immune response and gene changes affecting hair loss.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Non-immune factors play a significant role in alopecia areata.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Hydroxychloroquine may help treat alopecia areata in children.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.